KBC Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $169M | Buy |
672,932
+3,285
| +0.5% | +$707K | 0.37% | 51 |
|
|
2026
Q1 | $146M | Buy |
+669,647
| New | +$149M | 0.37% | 52 |
|
|
2025
Q4 | – | Sell |
-1,129,511
| Closed | -$262M | – | 1729 |
|
|
2025
Q3 | $262M | Buy |
1,129,511
+21,802
| +2% | +$4.44M | 0.63% | 23 |
|
|
2025
Q2 | $206M | Buy |
1,107,709
+3,589
| +0.3% | +$667K | 0.56% | 26 |
|
|
2025
Q1 | $231M | Sell |
1,104,120
-42,430
| -4% | -$8.25M | 0.72% | 21 |
|
|
2024
Q4 | $204M | Buy |
1,146,550
+54,501
| +5% | +$10M | 0.56% | 26 |
|
|
2024
Q3 | $216M | Buy |
1,092,049
+409,214
| +60% | +$76.4M | 0.65% | 20 |
|
|
2024
Q2 | $117M | Sell |
682,835
-147,918
| -18% | -$24.5M | 0.35% | 51 |
|
|
2024
Q1 | $151M | Sell |
830,753
-241,488
| -23% | -$41.6M | 0.48% | 39 |
|
|
2023
Q4 | $166M | Buy |
1,072,241
+52,489
| +5% | +$7.65M | 0.59% | 31 |
|
|
2023
Q3 | $152M | Buy |
1,019,752
+126,654
| +14% | +$18.6M | 0.62% | 28 |
|
|
2023
Q2 | $120M | Sell |
893,098
-177,367
| -17% | -$26M | 0.49% | 44 |
|
|
2023
Q1 | $171M | Sell |
1,070,465
-322,730
| -23% | -$49.3M | 0.72% | 25 |
|
|
2022
Q4 | $225M | Sell |
1,393,195
-39,488
| -3% | -$6.05M | 1.09% | 15 |
|
|
2022
Q3 | $192M | Buy |
1,432,683
+213,127
| +17% | +$30.6M | 1% | 13 |
|
|
2022
Q2 | $187M | Buy |
1,219,556
+449,340
| +58% | +$68.7M | 0.93% | 18 |
|
|
2022
Q1 | $125M | Buy |
770,216
+203,722
| +36% | +$29.6M | 0.49% | 46 |
|
|
2021
Q4 | $76.7M | Buy |
566,494
+196,338
| +53% | +$23.2M | 0.25% | 101 |
|
|
2021
Q3 | $39.9M | Sell |
370,156
-25,359
| -6% | -$2.9M | 0.15% | 167 |
|
|
2021
Q2 | $44.6M | Buy |
395,515
+11,488
| +3% | +$1.29M | 0.16% | 147 |
|
|
2021
Q1 | $41.6M | Sell |
384,027
-88,762
| -19% | -$9.49M | 0.17% | 148 |
|
|
2020
Q4 | $50.7M | Sell |
472,789
-179,077
| -27% | -$17.2M | 0.23% | 107 |
|
|
2020
Q3 | $57.1M | Sell |
651,866
-695,571
| -52% | -$65.5M | 0.34% | 73 |
|
|
2020
Q2 | $132M | Buy |
1,347,437
+610,839
| +83% | +$53.8M | 0.87% | 22 |
|
|
2020
Q1 | $56.1M | Buy |
736,598
+197,289
| +37% | +$16.8M | 0.47% | 40 |
|
|
2019
Q4 | $47.8M | Sell |
539,309
-105,174
| -16% | -$8.73M | 0.3% | 69 |
|
|
2019
Q3 | $48.8M | Buy |
644,483
+44,101
| +7% | +$3.02M | 0.36% | 56 |
|
|
2019
Q2 | $43.7M | Buy |
600,382
+38,200
| +7% | +$3M | 0.34% | 61 |
|
|
2019
Q1 | $45.3M | Buy |
562,182
+267,193
| +91% | +$21.9M | 0.37% | 55 |
|
|
2018
Q4 | $27.2M | Sell |
294,989
-72,772
| -20% | -$6.4M | 0.3% | 76 |
|
|
2018
Q3 | $34.8M | Buy |
367,761
+115,494
| +46% | +$11M | 0.26% | 96 |
|
|
2018
Q2 | $23.4M | Sell |
252,267
-534,170
| -68% | -$52.2M | 0.2% | 136 |
|
|
2018
Q1 | $74.4M | Sell |
786,437
-167,512
| -18% | -$18.4M | 0.69% | 21 |
|
|
2017
Q4 | $92.3M | Sell |
953,949
-377,714
| -28% | -$35.6M | 0.79% | 18 |
|
|
2017
Q3 | $118M | Buy |
1,331,663
+857,603
| +181% | +$65.3M | 1.07% | 12 |
|
|
2017
Q2 | $34.4M | Sell |
474,060
-10,236
| -2% | -$688K | 0.33% | 70 |
|
|
2017
Q1 | $31.6M | Sell |
484,296
-69,931
| -13% | -$4.4M | 0.28% | 80 |
|
|
2016
Q4 | $34.7M | Buy |
554,227
+169,353
| +44% | +$10.3M | 0.34% | 63 |
|
|
2016
Q3 | $24.3M | Buy |
384,874
+119,209
| +45% | +$7.72M | 0.29% | 80 |
|
|
2016
Q2 | $16.4M | Buy |
265,665
+24,186
| +10% | +$1.47M | 0.24% | 103 |
|
|
2016
Q1 | $13.8M | Sell |
241,479
-51,417
| -18% | -$2.87M | 0.23% | 99 |
|
|
2015
Q4 | $17.4M | Sell |
292,896
-53,883
| -16% | -$3.1M | 0.32% | 77 |
|
|
2015
Q3 | $18.9M | Sell |
346,779
-71,133
| -17% | -$4.63M | 0.38% | 65 |
|
|
2015
Q2 | $28.1M | Sell |
417,912
-31,305
| -7% | -$2.04M | 0.36% | 71 |
|
|
2015
Q1 | $26.3M | Buy |
449,217
+9,742
| +2% | +$589K | 0.34% | 83 |
|
|
2014
Q4 | $28.8M | Buy |
439,475
+361,503
| +464% | +$22.8M | 0.34% | 66 |
|
|
2014
Q3 | $4.5M | Sell |
77,972
-235,132
| -75% | -$13.1M | 0.16% | 181 |
|
|
2014
Q2 | $17.7M | Sell |
313,104
-20,000
| -6% | -$1.05M | 0.2% | 117 |
|
|
2014
Q1 | $17.1M | Sell |
333,104
-133,759
| -29% | -$6.76M | 0.27% | 81 |
|
|
2013
Q4 | $24.7M | Sell |
466,863
-24,453
| -5% | -$1.2M | 0.37% | 60 |
|
|
2013
Q3 | $22M | Buy |
491,316
+27,001
| +6% | +$1.2M | 0.35% | 61 |
|
|
2013
Q2 | $19.2M | Buy |
+464,315
| New | +$20.3M | 0.36% | 63 |
|
Other funds holding ABBV
KBC Group's ABBV Position: Q2 2026 in Review
KBC Group increased its AbbVie (ABBV) stake by 0.49% in Q2 2026, buying an estimated $707K and bringing the position to 672,932 shares worth $169M. The position accounts for 0.37% of the portfolio, ranked #51.
KBC Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $262M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- KBC Group held 672,932 shares of AbbVie worth $169M as of Q2 2026.
- KBC Group bought 3,285 AbbVie shares in Q2 2026, an estimated $707K.
- AbbVie made up 0.37% of KBC Group's portfolio in Q2 2026, its #51 holding.
- KBC Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- KBC Group's AbbVie position peaked at $262M in Q3 2025.
- 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.